Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Temozolomide and Olaparib for O6-Methylguanine DNA Methyltransferase Promoter Hypermethylated Colorectal Cancer

NCT04166435 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04166435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04166435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Temozolomide and Olaparib for O6-Methylguanine DNA Methyltransferase Promoter Hypermethylated Colorectal Cancer
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
June 17, 2020
Completion date
June 12, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer